Page 107 - 2022-33-中国全科医学

·4200· http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn

and intervention effects in heart failure patients of Chinese： GONG S，WANG L F，YU G L. Efficacy and risk assessment of
Meta-analysis［J］. Chinese Journal of Clinicians（Electronic antidepressant and anti-anxiety drugs in patients with cardiovascular
Edition），2014，8（4）：702-709. DOI：10.3877/cma. disease［J］. Herald of Medicine，2018，37（10）：1194-1198.
j.issn.1674-0785.2014.04.027. DOI：10.3870/j.issn.1004-0781.2018.10.010.
［8］GRIPPO A J，JOHNSON A K. Stress，depression and cardiovascular ［20］唐梅，李向平 . 抗抑郁药的不良反应及其在心血管病患者中
dysregulation：a review of neurobiological mechanisms and the 的应用［J］. 中南大学学报（医学版），2020，45（10）：
integration of research from preclinical disease models［J］. Stress， 1228-1233. DOI：10.11817/j.issn.1672-7347.2020.190160.
2009，12（1）：1-21. DOI：10.1080/10253890802046281. TANG M，LI X P. Adverse reactions of antidepressant drugs and
［9］BROTMAN D J，GOLDEN S H，WITTSTEIN I S. The their application in patients with cardiovascular diseases［J］.
cardiovascular toll of stress［J］. Lancet，2007，370（9592）： Journal of Central South University（Medical Science），
1089-1100. DOI：10.1016/S0140-6736（07）61305-1. 2020，45（10）：1228-1233. DOI：10.11817/j.issn.1672-
［10］DUNLAY S M，ROGER V L，REDFIELD M M. Epidemiology of 7347.2020.190160.
heart failure with preserved ejection fraction［J］. Nat Rev Cardiol， ［21］郭宁红，刘萧，李帅，等 . 抗抑郁药与心力衰竭患者死亡率
2017，14（10）：591-602. DOI：10.1038/nrcardio.2017.65. 关系的荟萃分析［J］. 临床心血管病杂志，2018，34（2）：
［11］PAULUS W J，TSCHÖPE C. A novel paradigm for heart failure 142-146. DOI：10.13201/j.issn.1001-1439.2018.02.010.
with preserved ejection fraction：comorbidities drive myocardial GUO N H，LIU X，LI S，et al. The relationship between
dysfunction and remodeling through coronary microvascular antidepressant treatment and mortality risk in heart failure patients：
endothelial inflammation［J］. J Am Coll Cardiol，2013，62（4）： a Meta-analysis［J］. Journal of Clinical Cardiology，2018，34（2）：
263-271. DOI：10.1016/j.jacc.2013.02.092. 142-146. DOI：10.13201/j.issn.1001-1439.2018.02.010.
［12］FELGER J C，LOTRICH F E. Inflammatory cytokines in ［22］YUSUF S，PFEFFER M A，SWEDBERG K，et al. Effects of
depression：neurobiological mechanisms and therapeutic candesartan in patients with chronic heart failure and preserved left-
implications［J］. Neuroscience，2013，246：199-229. DOI： ventricular ejection fraction：the CHARM-Preserved Trial［J］.
10.1016/j.neuroscience.2013.04.060. Lancet，2003，362（9386）：777-781. DOI：10.1016/S0140-
［13］SU J，WANG J H，MA Y Y，et al. Inflammation associated 6736(03)14285-7.
with chronic heart failure leads to enhanced susceptibility to ［23］RECTOR T S，CARSON P E，ANAND I S，et al. Assessment
depression［J］. FEBS J，2019，286（14）：2769-2786. DOI： of long-term effects of irbesartan on heart failure with preserved
10.1111/febs.14839. ejection fraction as measured by the Minnesota living with heart
［14］ZHAO X N，CAO F R，LIU Q，et al. Behavioral，inflammatory failure questionnaire in the irbesartan in heart failure with preserved
and neurochemical disturbances in LPS and UCMS-induced mouse systolic function（I-PRESERVE） trial［J］. Circ Heart Fail，
models of depression［J］. Behav Brain Res，2019，364：494- 2012，5（2）：217-225. DOI：10.1161/CIRCHEARTFAILU
502. DOI：10.1016/j.bbr.2017.05.064. RE.111.964221.
［15］DICKENS C. Depression in people with coronary heart disease： ［24］YAMAMOTO K，ORIGASA H，HORI M，et al. Effects of
prognostic significance and mechanisms［J］. Curr Cardiol Rep， carvedilol on heart failure with preserved ejection fraction：the
2015，17（10）：83. DOI：10.1007/s11886-015-0640-6. Japanese Diastolic Heart Failure Study（J-DHF）［J］. Eur J
［16］SCHERF-CLAVEL M，WURST C，NITSCHKE F，et al. Heart Fail，2013，15（1）：110-118. DOI：10.1093/eurjhf/
Extent of cortisol suppression at baseline predicts improvement hfs141.
in HPA axis function during antidepressant treatment［J］. ［25］PITT B，PFEFFER M A，ASSMANN S F，et al. Spironolactone for
Psychoneuroendocrinology，2020，114：104590. DOI：10.1016/j. heart failure with preserved ejection fraction［J］. N Engl J Med，
psyneuen.2020.104590. 2014，370（15）：1383-1392. DOI：10.1056/NEJMoa1313731.
［17］曹娟，刘习建，龚婷，等 . 冠心病与抑郁症共病机制及治疗的 ［26］NASSIF M E，WINDSOR S L，BORLAUG B A，et al. The SGLT2
研究进展［J］. 生命的化学，2019，39（5）：993-997. DOI： inhibitor dapagliflozin in heart failure with preserved ejection
10.13488/j.smhx.20190009. fraction：a multicenter randomized trial［J］. Nat Med，2021，27
CAO J，LIU X J，GONG T，et al. Progress on the mechanism （11）：1954-1960. DOI：10.1038/s41591-021-01536-x.
and treatment of patients with coronary artery disease and comorbid ［27］MUHAMMAD R N，AHMED L A，ABDUL SALAM R M，et al.
depression［J］. Chemistry of Life，2019，39（5）：993-997. Crosstalk among NLRP3 inflammasome，ET B R signaling，and
DOI：10.13488/j.smhx.20190009. miRNAs in stress-induced depression-like behavior：a modulatory
［18］SAMA J，VAIDYA D，MUKHERJEE M，et al. Effects of clinical role for SGLT2 inhibitors［J］. Neurotherapeutics，2021，18（4）：
depression on left ventricular dysfunction in patients with acute 2664-2681. DOI：10.1007/s13311-021-01140-4.
coronary syndrome［J］. J Thromb Thrombolysis，2021，51（3）： ［28］ PIESKE B，WACHTER R，SHAH S J，et al. Effect of sacubitril/
693-700. DOI：10.1007/s11239-020-02268-4. valsartan vs standard medical therapies on plasma NT-proBNP
［19］龚山，王龙飞，余国龙 . 心血管疾病患者使用抗抑郁焦虑药 concentration and submaximal exercise capacity in patients with
物效益与风险评估［J］. 医药导报，2018，37（10）：1194- heart failure and preserved ejection fraction：the PARALLAX
1198. DOI：10.3870/j.issn.1004-0781.2018.10.010. randomized clinical trial［J］. JAMA，2021，326（19）：1919-